Literature DB >> 11254665

The SAMP1/Yit mouse: another step closer to modeling human inflammatory bowel disease.

W Strober1, K Nakamura, A Kitani.   

Abstract

Entities:  

Mesh：

Year:  2001        PMID： 11254665      PMCID： PMC208954          DOI： 10.1172/JCI12559

Source DB:  PubMed          Journal:  J Clin Invest        ISSN： 0021-9738            Impact factor:   14.808


× No keyword cloud information.
  25 in total

1.  Lactobacillus species prevents colitis in interleukin 10 gene-deficient mice.

Authors:  K L Madsen; J S Doyle; L D Jewell; M M Tavernini; R N Fedorak
Journal:  Gastroenterology       Date:  1999-05       Impact factor: 22.682

2.  HISTOLOGIC AND IMMUNOHISTOCHEMICAL FEATURES OF THE AUER "COLITIS" IN RABBITS.

Authors:  S C KRAFT; F W FITCH; J B KIRSNER
Journal:  Am J Pathol       Date:  1963-12       Impact factor: 4.307

Review 3.  Animal models of mucosal inflammation and their relation to human inflammatory bowel disease.

Authors:  R S Blumberg; L J Saubermann; W Strober
Journal:  Curr Opin Immunol       Date:  1999-12       Impact factor: 7.486

Review 4.  The C3H/HeJBir mouse model: a high susceptibility phenotype for colitis.

Authors:  C O Elson; Y Cong; J Sundberg
Journal:  Int Rev Immunol       Date:  2000       Impact factor: 5.311

5.  Cutting edge: chronic intestinal inflammation in STAT-4 transgenic mice: characterization of disease and adoptive transfer by TNF- plus IFN-gamma-producing CD4+ T cells that respond to bacterial antigens.

Authors:  S Wirtz; S Finotto; S Kanzler; A W Lohse; M Blessing; H A Lehr; P R Galle; M F Neurath
Journal:  J Immunol       Date:  1999-02-15       Impact factor: 5.422

6.  Inflammatory bowel disease-like enteritis and caecitis in a senescence accelerated mouse P1/Yit strain.

Authors:  S Matsumoto; Y Okabe; H Setoyama; K Takayama; J Ohtsuka; H Funahashi; A Imaoka; Y Okada; Y Umesaki
Journal:  Gut       Date:  1998-07       Impact factor: 23.059

7.  Resident enteric bacteria are necessary for development of spontaneous colitis and immune system activation in interleukin-10-deficient mice.

Authors:  R K Sellon; S Tonkonogy; M Schultz; L A Dieleman; W Grenther; E Balish; D M Rennick; R B Sartor
Journal:  Infect Immun       Date:  1998-11       Impact factor: 3.441

8.  The critical role of interleukin 4 but not interferon gamma in the pathogenesis of colitis in T-cell receptor alpha mutant mice.

Authors:  A Mizoguchi; E Mizoguchi; A K Bhan
Journal:  Gastroenterology       Date:  1999-02       Impact factor: 22.682

9.  An essential role for interleukin 10 in the function of regulatory T cells that inhibit intestinal inflammation.

Authors:  C Asseman; S Mauze; M W Leach; R L Coffman; F Powrie
Journal:  J Exp Med       Date:  1999-10-04       Impact factor: 14.307

10.  Oxazolone colitis: A murine model of T helper cell type 2 colitis treatable with antibodies to interleukin 4.

Authors:  M Boirivant; I J Fuss; A Chu; W Strober
Journal:  J Exp Med       Date:  1998-11-16       Impact factor: 14.307
View more
  16 in total

1.  In vivo demonstration of T lymphocyte migration and amelioration of ileitis in intestinal mucosa of SAMP1/Yit mice by the inhibition of MAdCAM-1.

Authors:  K Matsuzaki; Y Tsuzuki; H Matsunaga; T Inoue; J Miyazaki; R Hokari; Y Okada; A Kawaguchi; S Nagao; K Itoh; S Matsumoto; S Miura
Journal:  Clin Exp Immunol       Date:  2005-04       Impact factor: 4.330

2.  Role of interleukin 6 in a murine model of Crohn's ileitis: are cytokine/anticytokine strategies the future for IBD therapies?

Authors:  T T Pizarro; S A De La Rue; F Cominelli
Journal:  Gut       Date:  2006-09       Impact factor: 23.059

Review 3.  Leukocyte adhesion molecules in animal models of inflammatory bowel disease.

Authors:  Jesús Rivera-Nieves; Gezahegn Gorfu; Klaus Ley
Journal:  Inflamm Bowel Dis       Date:  2008-12       Impact factor: 5.325

4.  STAT3 activation via interleukin 6 trans-signalling contributes to ileitis in SAMP1/Yit mice.

Authors:  K Mitsuyama; S Matsumoto; S Rose-John; A Suzuki; T Hara; N Tomiyasu; K Handa; O Tsuruta; H Funabashi; J Scheller; A Toyonaga; M Sata
Journal:  Gut       Date:  2006-05-08       Impact factor: 23.059

Review 5.  Novel strategies for the treatment of inflammatory bowel disease: Selective inhibition of cytokines and adhesion molecules.

Authors:  Kazuhiko Nakamura; Kuniomi Honda; Takahiro Mizutani; Hirotada Akiho; Naohiko Harada
Journal:  World J Gastroenterol       Date:  2006-08-07       Impact factor: 5.742

6.  Decreased production of interleukin-10 and transforming growth factor-β in Toll-like receptor-activated intestinal B cells in SAMP1/Yit mice.

Authors:  Yoshiyuki Mishima; Shunji Ishihara; Md Monowar Aziz; Akihiko Oka; Ryusaku Kusunoki; Aya Otani; Yasumasa Tada; Yong-Yu Li; Ichiro Moriyama; Naoki Oshima; Takafumi Yuki; Yuji Amano; Satoshi Matsumoto; Yoshikazu Kinoshita
Journal:  Immunology       Date:  2010-12       Impact factor: 7.397

7.  Novel model of TH2-polarized chronic ileitis: the SAMP1 mouse.

Authors:  Eoin N McNamee; Joshua D Wermers; Joanne C Masterson; Colm B Collins; Matthew D P Lebsack; Sophie Fillon; Zachary D Robinson; Joanna Grenawalt; James J Lee; Paul Jedlicka; Glenn T Furuta; Jesçs Rivera-Nieves
Journal:  Inflamm Bowel Dis       Date:  2010-05       Impact factor: 5.325

Review 8.  Initiation and resolution of mucosal inflammation.

Authors:  Melanie A Sherman; Daniel Kalman
Journal:  Immunol Res       Date:  2004       Impact factor: 2.829

9.  Secreted Klotho Attenuates Inflammation-Associated Aortic Valve Fibrosis in Senescence-Accelerated Mice P1.

Authors:  Jianglei Chen; Jun Fan; Shirley Wang; Zhongjie Sun
Journal:  Hypertension       Date:  2018-03-26       Impact factor: 10.190

10.  Omega-3 polyunsaturated fatty acids ameliorate the severity of ileitis in the senescence accelerated mice (SAM)P1/Yit mice model.

Authors:  H Matsunaga; R Hokari; C Kurihara; Y Okada; K Takebayashi; K Okudaira; C Watanabe; S Komoto; M Nakamura; Y Tsuzuki; A Kawaguchi; S Nagao; S Miura
Journal:  Clin Exp Immunol       Date:  2009-09-30       Impact factor: 4.330
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.